Charles River Laboratories International Inc
NYSE:CRL
Charles River Laboratories International Inc
NYSE:CRL
Price:
176.99
USD
1.45%
Market Closed
Market Cap:
$8.7B
Relative Value
The Relative Value of one
CRL
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 176.99 USD,
Charles River Laboratories International Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CRL Relative Value
HIDDEN
Multiples Across Competitors
CRL Competitors Multiples
Charles River Laboratories International Inc Competitors
Charles River Laboratories International Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Charles River Laboratories International Inc
NYSE:CRL
|
8.7B USD | 2.2 | -60 | 11.7 | 21.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
994.8B USD | 348.3 | 4 124.2 | 1 181.7 | 2 275.6 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
191.9B USD | 4.3 | 28.6 | 20 | 26.8 | |
| US |
|
Danaher Corp
NYSE:DHR
|
140.5B USD | 5.7 | 38.9 | 19.7 | 28.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.6B CHF | 5.2 | 35.8 | 26.7 | 26.7 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
258.7B CNY | 5.9 | 17.4 | 17.5 | 17.5 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
33B USD | 4.7 | 25.6 | 20.1 | 24 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
30.3B USD | 1.9 | 22.4 | 12.3 | 18.4 | |
| US |
|
Waters Corp
NYSE:WAT
|
30B USD | 9.5 | 46.6 | 30.1 | 37.9 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.4B USD | 6.3 | 29.2 | 21.7 | 24.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
